Eliem Therapeutics, Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
6.00
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.53
|
0.00
|
0.53
|
100.00%
|
|
2022-12-31
|
-0.38
|
0.00
|
0.38
|
100.00%
|
|
2022-09-30
|
-0.43
|
-0.37
|
0.06
|
13.95%
|
|
2022-06-30
|
-0.47
|
-0.56
|
-0.09
|
-19.15%
|
|
2022-03-31
|
-0.56
|
-0.50
|
0.06
|
10.71%
|
|
2021-12-31
|
-0.62
|
-0.40
|
0.22
|
35.48%
|
|
2021-09-30
|
-0.92
|
-0.70
|
0.22
|
23.91%
|
|
2021-06-30
|
-1.86
|
-3.11
|
-1.25
|
-67.20%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.43
|
|
2021-12-31
|
-4.21
|